/PRNewswire/ BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a $3.0M AUD grant.
Switching batch production for continuous manufacturing is less of a technical challenge than a cultural one, according to an expert who cites regulatory support and innovation in bioprocessing systems. Continuous manufacturing has potential advantages over batch-mode production in terms of efficiency, yields, and waste reduction. Despite this, use of the approach has been mainly limited to perfusion systems in upstream culturing.